- Home
- Products
- Customized FluoroAb™
- CD19
- Blinatumomab-iFluor 568
Blinatumomab-iFluor 568 (CAT#: ADC-FL-385)
This product is comprised of an anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody (Blinatumomab) labeled with iFluor 568. iFluor 568 is a orange-fluorescent dye and it's excitation/emission is 578/603 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD19
- Alternative Names
- CD19; CD19 molecule; CD19 antigen; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4; B4; CVID3; MGC12802;
- Overview
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
- Overview
- Anti-CD19 (scFv-kappa-heavy)-(scFv-heavy-kappa) antibody, Blinatumomab
- Generic name
- Blinatumomab
- Species Reactivity
- Human
- Name
- iFluor 568
- Color
- Orange
- Excitation⁄Emission (nm)
- 578/603
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CTLA4 MAb (Clone 13)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2783)
- Anti-CD19 MAb (Clone 14)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS920)
- Anti-HBV MAb (Clone 3)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10813)
- Bapineuzumab-iFluor 647 (CAT#: ADC-FL-171)
- Anti-KDR MAb (Clone 8)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10245)
- Anti-FOLR1 MAb (Clone 8)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5615)
- Anti-IL2RA MAb (Clone 8)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14902)
- Tacatuzumab-iFluor 680 (CAT#: ADC-FL-028)
- Anti-MSLN MAb (Clone 9)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4082)
- Anti-CTAA16.88 MAb (Clone 2)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS6194)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-385. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-775 | Anti-CD19 (Taplitumomab paptox)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-2517 | Anti-CD19 (Denintuzumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2516 | Anti-CD19 (Denintuzumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2518 | Anti-CD19 (Denintuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-776 | Anti-CD19 (Blinatumomab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
